Literature DB >> 6695906

Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.

O Castro, A E Nesbitt, D Lyles.   

Abstract

To study the effect of a perfluorocarbon oxygen transport emulsion (Fluosol-DA) on reticuloendothelial system (RES) function, we measured the blood clearance of human erythrocytes transfused to rats. Compared with saline treatment, Fluosol-DA at 30 ml/kg doses significantly increased both the percent 20-hour blood recovery (mean 8.9% +/- 2.7 SEM vs 1.3% +/- 0.25 SEM) and 51Cr t1/2 survival (mean 14.0 hours +/- 2.7 SEM vs 3.5 hours +/- 0.33 SEM) of the human red cells. This suppression of RES clearance function was transient and no longer detectable seven days after single Fluosol-DA doses. The Fluosol-DA-induced RES block was about three times greater than that obtainable with 4 g/kg of a soybean oil emulsion used for clinical hyperalimentation. On the other hand, the effect of ethyl palmitate (0.5 g/kg), a potent but toxic RES blocker, was 3.5 times greater than that of Fluosol-DA in this test system. If Fluosol-DA also induces RES block in humans, this emulsion could be explored as a therapeutic RES blocker in certain immune cytopenias.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695906     DOI: 10.1002/ajh.2830160103

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.

Authors:  Deepak K K Kadayakkara; Jelena M Janjic; Lisa K Pusateri; Won-Bin Young; Eric T Ahrens
Journal:  Magn Reson Med       Date:  2010-09-21       Impact factor: 4.668

Review 2.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

3.  Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response.

Authors:  Corby Fink; Michael Smith; Jeffrey M Gaudet; Ashley Makela; Paula J Foster; Gregory A Dekaban
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

4.  Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.

Authors:  Dina V Hingorani; Fanny Chapelin; Emma Stares; Stephen R Adams; Hideho Okada; Eric T Ahrens
Journal:  Magn Reson Med       Date:  2019-10-21       Impact factor: 4.668

Review 5.  In vivo imaging of immune cell trafficking in cancer.

Authors:  Luisa Ottobrini; Cristina Martelli; Daria Lucia Trabattoni; Mario Clerici; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-18       Impact factor: 9.236

6.  Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Authors:  Brooke M Helfer; Anthony Balducci; Aaron D Nelson; Jelena M Janjic; Roberto R Gil; Pawel Kalinski; I Jolanda M de Vries; Eric T Ahrens; Robbie B Mailliard
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

7.  Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats.

Authors:  J Lutz; M Stark
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

Review 8.  Fluorine-containing nanoemulsions for MRI cell tracking.

Authors:  Jelena M Janjic; Eric T Ahrens
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Sep-Oct

Review 9.  In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection.

Authors:  Eric T Ahrens; Jia Zhong
Journal:  NMR Biomed       Date:  2013-04-22       Impact factor: 4.044

10.  In vivo cytometry of antigen-specific t cells using 19F MRI.

Authors:  Mangala Srinivas; Michael S Turner; Jelena M Janjic; Penelope A Morel; David H Laidlaw; Eric T Ahrens
Journal:  Magn Reson Med       Date:  2009-09       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.